| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.087 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |